Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV 2 Infection”

641 trials

Showing 20 of 641 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT04958889
What this trial is testing

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)HIV
Johns Hopkins University 392
Testing effectiveness (Phase 2)Looking for participantsNCT04305691
What this trial is testing

Trial of Ixazomib for Kaposi Sarcoma

Who this might be right for
Kaposi SarcomaSkin
AIDS Malignancy Consortium 41
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Large-scale testing (Phase 3)Study completedNCT00670839
What this trial is testing

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Who this might be right for
Hepatitis BHIV Infection
ANRS, Emerging Infectious Diseases 178
Not applicableUnknownNCT03931083
What this trial is testing

Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV

Who this might be right for
Uterine Cervical NeoplasmsHIV/AIDS
University of Bern 450
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Study completedNCT02029430
What this trial is testing

Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Who this might be right for
Kaposi's SarcomaHIV PositiveAIDS
ImmunityBio, Inc. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04337450
What this trial is testing

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Who this might be right for
HIV Infections
PENTA Foundation 386
Early research (Phase 1)Study completedNCT02277600
What this trial is testing

Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Not applicableWithdrawnNCT01769911
What this trial is testing

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Post-approval studies (Phase 4)Study completedNCT00540137
What this trial is testing

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

Who this might be right for
HIV Infections
Imperial College London 21
Large-scale testing (Phase 3)Study completedNCT00000637
What this trial is testing

Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 819
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)Study completedNCT02373930
What this trial is testing

Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 63
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Early research (Phase 1)Study completedNCT00002180
What this trial is testing

PMPA in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences
Testing effectiveness (Phase 2)Study completedNCT02457689
What this trial is testing

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

Who this might be right for
HIV
Imperial College London 30
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation